Molecular Imaging

EANM: Next-generation PET scanner cuts imaging time to one minute
By Will Morton
The scanner's fastest images were rated more highly on average than those from a standard PET/CT scanner.
October 18, 2026
PET scan comparison showing SAFOV baseline and 1-minute and 5-minute time-point imaging with tracer uptake patterns
Capitol Imaging Services acquires Impression Imaging
By AuntMinnie.com staff writers
CIS said the deal is part of its expansion into molecular imaging and theranostics.
October 16, 2026
Two businessmen in suits shaking hands during a professional meeting
IBA gets order for 12 cyclotrons for U.S. PET tracer network
By AuntMinnie.com staff writers
A KIUBE 300 system typically costs between €2.5 million and €5 million.
October 16, 2026
IBA brand logo with white stylized text and circular symbol on green gradient background signage
AtomVie, Jubilant Radiopharma enter distribution partnership
By AuntMinnie.com staff writers
Jubilant will handle receipt, regulatory compliance, and distribution of AtomVie-manufactured radiopharmaceuticals.
October 15, 2026
Digital handshake with blue and orange technology network patterns symbolizing business partnership and innovation
Nusano, Primo Biotechnology ink isotope supply deal
By AuntMinnie.com staff writers
The agreement will support Primo’s cancer therapy pipeline.
October 14, 2026
Glowing atom symbol with blue and orange energy effects over laboratory equipment and scientific instruments
AuntMinnie.com Molecular Imaging Insider
By Will Morton
We’ve highlighted a secondary analysis of the LUNAR trial, with findings suggesting the benefits of lutetium-177 (Lu-177) PNT200 extend to more clinically meaningful disease states.
October 13, 2026
Lu-177 PNT2002 before SBRT extends disease control in prostate cancer
By Will Morton
A group from the University of California, Los Angeles, updated an analysis of outcomes from the LUNAR trial by 10 months.
October 13, 2026
X-ray scan of pelvis with highlighted prostate gland in red for medical diagnosis
Bayer touts I-124 evuzamitide PET study
By AuntMinnie.com staff writers
The presentation covered a post-hoc analysis from the phase III REVEAL study.
October 12, 2026
Anatomical illustration of a glowing human heart with coronary arteries highlighted in red and orange against a blue gradient background
Jubilant to invest 94.5M CAD in manufacturing facility
By AuntMinnie.com staff writers
The investment will double output of the firm's RubyFill rubidium-82 chloride cardiac PET agent.
October 9, 2026
Digital illustration of a glowing human heart with technological and medical monitoring elements integrated into a blue digital interface background.
Telix reports first patients dosed with Pixclara
By AuntMinnie.com staff writers
The FDA approved the PET imaging agent in September.
October 7, 2026
Glowing human brain illustration with blue and pink lighting on dark background
SNMMI: PSMA-PET/CT-guided biopsy improves prostate cancer detection
By Will Morton
The findings suggest that PSMA-PET/CT could provide an additional tool for identifying men who remain at risk despite nondiagnostic MRI findings.
October 7, 2026
PET-CT scan images showing axial and coronal views of abdomen with arrows indicating focal lesions in kidney and lower abdomen regions
Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer
By AuntMinnieEurope.com staff writers
The trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.
October 6, 2026
Nuclidium logo featuring blue atomic symbol with red accent and company name in sans-serif type
Page 1 of 636
Next Page